
Two lawsuits involving alleged contamination of water supplies in Chattooga County are scheduled for trial in 2027, according to a new federal securities filing by chemical manufacturer Chemours.
The company’s quarterly report, filed November 5 with the Securities and Exchange Commission, identifies a January 2027 trial setting for a federal lawsuit brought on behalf of residents of Summerville and Chattooga County. A separate lawsuit filed by the Town of Lyerly is scheduled for trial in June 2027.
The Summerville case involves allegations that PFAS chemicals, commonly called “forever chemicals,” contaminated drinking water supplies. The lawsuit names multiple defendants, including Chemours and EID, formerly associated with DuPont.
The case was expanded to include those companies in November 2022. Plaintiffs have raised claims involving negligence, nuisance and other alleged violations while seeking various forms of damages.
In September 2025, the federal court granted class certification for claims involving past damages from alleged PFAS contamination but denied certification for future damages.
The filing also reports that the court ruled on motions seeking summary judgment in July 2026, including denying a motion filed by Chemours and EID.
Meanwhile, the Town of Lyerly filed its own lawsuit in July 2024, alleging that PFAS chemicals entered its water supply as a result of carpet manufacturing operations or products supplied to those manufacturers.
Lyerly’s lawsuit includes claims of negligence, nuisance, trespass and regulatory violations. The town is seeking compensation for past and future expenses, punitive damages and attorneys’ fees.
Both Summerville and Lyerly have opted out of the nationwide public water system class-action settlement, according to the filing.
PFAS are a group of manufactured chemicals that can remain in the environment for extended periods. Their presence in drinking water has been the subject of litigation and environmental investigations throughout Northwest Georgia.
The allegations remain subject to litigation, and the trial settings do not establish liability on the part of the defendants.
The Chemours filing does not provide specific trial dates beyond the scheduled months of January and June 2027.







Comments